Free 25-Hydroxyvitamin D Is Associated With the Risk of Mortality in Subjects With Coronary Artery Disease (CAD)
Dr. Yu recently published a paper entitled “Serum Bioavailable and Free 25-Hydroxyvitamin D Levels, but Not ItsTotal Level, Are Associated With the Risk of Mortality in Patients With Coronary Artery Disease" (Circulation Research. 2018;123:996–1007).
A cohort of 1387 subjects with angiographically confirmed CAD was followed up during 6.7 years, and total 25OH Vitamin D, Bioavailable 25OH Vitamin D, and Free 25OH Vitamin D were measured at baseline and at endpoint.
The authors found out that Bioavailable and Free 25OH Vitamin D, but not Total 25OH Vitamin D, nor DBP, show a significant inverse association with the risk of both all-cause mortality, and cardiovascular mortality.
They conclude that this study demonstrates that bioavailable and free 25OH Vitamin D are potential predictors of adverse outcomes among CAD subjects.
Dr. Premer and Dr. Schulman wrote an editorial about this study, entitled "Have We Been Measuring the Wrong Form of Vitamin D? Vitamin D as a Prognostic Biomarker for Coronary Artery Disease Mortality" (https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.118.313814).
Albeit they cautioned the role ethnicity may have played in this study, as all participating subjects were Chinese—a population with relatively lower levels of CAD mortality compared with the Western population, they wondered how the measurement of bioavailable and free 25-hydroxyvitamin D in prior clinical trials would have affected the results. Furthermore, does changing the specific forms of vitamin D levels that are measured translate into meaningful clinical therapeutic advancements?
According to their opinion, Yu et al makes an important contribution to the field by demonstrating that total 25-hydroxyvitamin D—a parameter that has been commonly used to assess vitamin D body stores—is perhaps not what we should be measuring, but rather bioavailable and free 25-hydroxyvitamin D.
The article is available at https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.118.313558.
More information: Free 25OH Vitamin D ELISA
We are proud to announce Professor Yusuke Suzuki and Associate Professor Hitoshi Suzuki, Juntendo University Faculty of Medicine in Tokyo, Japan will present the following poster at ASN Kidney Week. Scheduled Date: October 25, 2018 (Thursday) 10AM Category: 1202 Glomerular Disease: Immunology and Inflammation – I Poster Number: TH-PO0822 Poster Title: Urinary Galactose-Deficient IgA1 Represent a Disease-Specific Marker of IgA [...]
Society for Neuroscience's 48th annual meeting, Neuroscience 2018, is the world’s largest neuroscience conference for scientists and physicians devoted to understanding the brain and nervous system. Neuroscience 2018 is where neuroscientists collaborate and network with peers, learn from experts, explore the newest neuroscience tools and technologies, and discover great career opportunities. Join more than 30,000 colleagues from [...]
Join our team and more than 13,000 other kidney professionals from across the globe at Kidney Week 2018 in San Diego, CA. The world's premier nephrology meeting, Kidney Week provides participants exciting and challenging opportunities to exchange knowledge, learn the latest scientific and medical advances, and listen to engaging and provocative discussions with leading experts [...]
The accurate measurement of active GLP-1 in blood is considered critical for basic and clinical research of diabetes.Measuring active GLP-1 in blood without the influence of non-specific reactions made by Heterophilic Antibodies (HA), especially HAMA (Human Anti-Mouse Antibodies) is required for obtaining accurate active GLP-1 values and Solid-Phase Extraction: SPE pre-treatment is typically needed. However, [...]
The complement system is part of the host defense with a number of biological effects, most of which contribute to the inflammatory reaction mainly by activation of cells like leukocytes and endothelial cells. An intact complement system is required for protection against infection and for maintaining the internal inflammatory homeostasis. However, the system is a [...]
TNF inhibitors are a type of drug used worldwide to treat inflammatory conditions such as rheumatoid arthritis (RA), psoriatic arthritis, juvenile arthritis, inflammatory bowel disease (Crohn’s and ulcerative colitis), ankylosing spondylitis, and psoriasis. They reduce inflammation and stop disease progression by targeting an inflammation-causing substance called Tumor Necrosis Factor (TNF). In healthy individuals, excess TNF in [...]
(Pro)renin receptor/(P)RR is a common receptor protein between renin and prorenin. When prorenin binds to (P)RR, it achieves a binding ability to angiotensinogen and gains a catalytic activity for conversion from angiotensinogen to ansiotensin I in a comparable level with renin. Additionally, when the (P)RR is stimulated by binding to prorenin, its intracellular signaling progresses. [...]
Visit our team at the 31st Annual Association of Medical Laboratory Immunologists (AMLI) Scientific Meeting! Each year the AMLI holds an annual meeting that presents cutting edge science from various fields related to clinical and diagnostic laboratory immunology. This event serves as a forum for clinical immunologists to meet, learn and discuss common interests. The annual [...]
Serotonin (5-hydroxytryptamine) belongs to the group of biogenic amines and is an intermediate product of the tryptophan metabolism. It plays an important role as a neurotransmitter in the regulation of different behavioral patterns such as motor activity, aggression, sexuality, appetite, and sleep. Diseases which are associated with altered serotonin concentrations include disorders of the CNS, for [...]